241 related articles for article (PubMed ID: 29941432)
1. The evolving epidemiology of
Katz KC; Golding GR; Choi KB; Pelude L; Amaratunga KR; Taljaard M; Alexandre S; Collet JC; Davis I; Du T; Evans GA; Frenette C; Gravel D; Hota S; Kibsey P; Langley JM; Lee BE; Lemieux C; Longtin Y; Mertz D; Mieusement LMD; Minion J; Moore DL; Mulvey MR; Richardson S; Science M; Simor AE; Stagg P; Suh KN; Taylor G; Wong A; Thampi N;
CMAJ; 2018 Jun; 190(25):E758-E765. PubMed ID: 29941432
[TBL] [Abstract][Full Text] [Related]
2. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015.
Oñate-Gutiérrez JM; Segura J; Correa A; Cantor E; Villegas MV
Biomedica; 2019 May; 39(s1):63-70. PubMed ID: 31529849
[TBL] [Abstract][Full Text] [Related]
5. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
[TBL] [Abstract][Full Text] [Related]
6. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
7. NAP1 strain type predicts outcomes from Clostridium difficile infection.
See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
[TBL] [Abstract][Full Text] [Related]
8. Healthcare-Associated Clostridium difficile Infections and Strain Diversity in Pediatric Hospitals in the Canadian Nosocomial Infection Surveillance Program, 2007-2011.
Le Saux N; Gravel D; Mulvey M; Moore D; Langley JM; Richardson S; Quach C; Choi KB; Miller M; Katz K;
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e151-4. PubMed ID: 26407250
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007.
Karlowsky JA; Zhanel GG; Hammond GW; Rubinstein E; Wylie J; Du T; Mulvey MR; Alfa MJ
J Med Microbiol; 2012 May; 61(Pt 5):693-700. PubMed ID: 22301615
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
[TBL] [Abstract][Full Text] [Related]
11. The burden of Clostridium difficile in surgical patients in the United States.
Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
[TBL] [Abstract][Full Text] [Related]
12. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.
Hubert B; Loo VG; Bourgault AM; Poirier L; Dascal A; Fortin E; Dionne M; Lorange M
Clin Infect Dis; 2007 Jan; 44(2):238-44. PubMed ID: 17173224
[TBL] [Abstract][Full Text] [Related]
13. Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.
Quesada-Gómez C; López-Ureña D; Acuña-Amador L; Villalobos-Zúñiga M; Du T; Freire R; Guzmán-Verri C; del Mar Gamboa-Coronado M; Lawley TD; Moreno E; Mulvey MR; de Castro Brito GA; Rodríguez-Cavallini E; Rodríguez C; Chaves-Olarte E
J Clin Microbiol; 2015 Apr; 53(4):1216-26. PubMed ID: 25653402
[TBL] [Abstract][Full Text] [Related]
14. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Tart SB
J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
[TBL] [Abstract][Full Text] [Related]
15. Host and pathogen factors for Clostridium difficile infection and colonization.
Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
[TBL] [Abstract][Full Text] [Related]
18. Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama.
López-Ureña D; Quesada-Gómez C; Miranda E; Fonseca M; Rodríguez-Cavallini E
J Med Microbiol; 2014 Feb; 63(Pt 2):322-324. PubMed ID: 24287669
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
